Table 1.
Characteristic | Value |
---|---|
Median age (range, yrs) | 64 (27–84) |
Male sex | 127 (59%) |
Race | |
White | 180 (84%) |
Black | 18 (8%) |
Asian | 9 (4%) |
Native American | 1 (0.5%) |
Other | 6 (3%) |
Hematologic neoplasm | |
Lymphoid* | 149 (70%) |
Myeloid† | 65 (30%) |
HCT | 15 (7%) |
Allogeneic | 3/15 (20%) |
Autologous | 12/15 (80%) |
HCV genotype | |
1b | 2/2 (100%) |
Data are median (range) or n (%).
HCT = hematopoietic cell transplant; HCV = hepatitis C virus.
Lymphoid neoplasms included the following categories based on the 2016 World Health Organization classification: mature B-cell neoplasms and Hodgkin lymphoma.
Myeloid neoplasms included the following categories based on the 2016 World Health Organization classification: myeloproliferative neoplasms, myelodysplastic/myeloproliferative neoplasms, myelodysplastic syndromes, acute myeloid leukemia, and related neoplasms, and B-lymphoblastic leukemia/lymphoma.